Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesDiseases and Disorders of the Digestive SystemDRG 375-digestive-malignancy-with-cc
    Ask Trek AI about this page

    Digestive Malignancy with CC: Inpatient Reimbursement Overview

    DRG 375 addresses hospital stays for malignant digestive system conditions with at least one Complication or Comorbidity, encompassing cancers of the gastrointestinal tract and associated organs when additional clinical complexities are present. This classification matters for inpatient reimbursement because the presence of a Complication or Comorbidity alters resource intensity and influences the Medicare Severity Diagnosis-Related Group-based payment amount.

    Customize your policy alerts

    Sign up for drg 375 policy alerts

    Get alerted when payer policies referencing 375 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 375 Overview

    DRG 375 covers hospital admissions for patients with malignant gastrointestinal conditions where a Complication or Comorbidity is present, reflecting cases more complex than those without such additional diagnoses. This category typically includes malignancies of the stomach, small intestine, colon, rectum, liver, pancreas, and biliary tract when accompanied by an identified Complication or Comorbidity that affects resource use. It matters for Medicare payment because the presence of a Complication or Comorbidity increases expected resource consumption and therefore adjusts the inpatient reimbursement relative to less complex malignant digestive cases. Accurate coding of the principal diagnosis and any Complications or Comorbidities directly affects the assigned Diagnosis-Related Group and consequent Medicare Severity Diagnosis-Related Group-based payment.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Perioperative optimization and enhanced recovery trials: Studies in this area evaluate prehabilitation, nutritional interventions, and multimodal pain control protocols for patients undergoing surgery for digestive tract malignancies (e.g., stomach, small bowel, colon, rectum, hepatobiliary neoplasms) who present with complicating conditions such as malnutrition, anemia, or infection. These trials typically enroll hospitalized patients scheduled for elective or urgent resection and measure metrics like complication rates, length of stay, readmission, and short-term functional recovery. Results are directly relevant to inpatient providers who must manage surgical risk and to payers because improved perioperative pathways can reduce costly complications and resource use associated with this DRG.
    • Comparative effectiveness studies of systemic and locoregional therapies in patients with advanced or locally complicated digestive malignancies: These trials compare outcomes (tumor response, symptom control, progression-free survival, and hospitalization burden) between different systemic regimens, combinations with locoregional approaches (such as embolization or localized ablation), or timing strategies for patients with metastatic or recurrent disease who often require inpatient care for complications. Patient populations include those with CC (complications/comorbidities) like biliary obstruction, bleeding, or treatment-related toxicity; the clinical question centers on which approaches reduce hospital admissions and severe adverse events while delivering meaningful disease control. Payers and hospital administrators value this research because choosing more effective or lower-toxicity strategies can decrease inpatient utilization, ICU transfers, and downstream costs tied to this DRG.
    • Post-discharge outcomes and care coordination research focusing on complication prevention and palliative transitions: These prospective observational studies and intervention trials test discharge planning models, home-based symptom management, and early palliative care integration for patients hospitalized with digestive malignancies who have complications or comorbidities that increase readmission risk. Enrolled patients are those discharged after treatment for obstruction, infection, or treatment complications, and studies measure 30- and 90-day readmissions, emergency visits, symptom burden, and patient-centered outcomes. Findings inform inpatient clinicians and payers about which transition-of-care interventions reduce readmissions, align care with patient goals, and optimize resource use for a population that frequently returns to the hospital.

    Related Codes

    326-STOMACH-ESOPHAGEAL-AND-DUODENAL-PROCEDURES-WITH-MCC

    Stomach, Esophageal and Duodenal Procedures with MCC: Inpatient Reimbursement Overview

    327-STOMACH-ESOPHAGEAL-AND-DUODENAL-PROCEDURES-WITH-CC

    Stomach, Esophageal and Duodenal Procedures with CC: Inpatient Reimbursement Overview

    328-STOMACH-ESOPHAGEAL-AND-DUODENAL-PROCEDURES-WITHOUT-CC-MCC

    Stomach, Esophageal and Duodenal Procedures without CC/MCC: Inpatient Reimbursement Overview

    329-MAJOR-SMALL-AND-LARGE-BOWEL-PROCEDURES-WITH-MCC

    Major Small and Large Bowel Procedures with MCC: Inpatient Reimbursement Overview

    330-MAJOR-SMALL-AND-LARGE-BOWEL-PROCEDURES-WITH-CC

    Major Small and Large Bowel Procedures with CC: Inpatient Reimbursement Overview

    331-MAJOR-SMALL-AND-LARGE-BOWEL-PROCEDURES-WITHOUT-CC-MCC

    Major Small and Large Bowel Procedures without CC/MCC: Inpatient Reimbursement Overview

    332-RECTAL-RESECTION-WITH-MCC

    Rectal Resection with MCC: Inpatient Reimbursement Overview

    333-RECTAL-RESECTION-WITH-CC

    Rectal Resection with CC: Inpatient Reimbursement Overview

    334-RECTAL-RESECTION-WITHOUT-CC-MCC

    Rectal Resection without CC/MCC: Inpatient Reimbursement Overview

    335-PERITONEAL-ADHESIOLYSIS-WITH-MCC

    Peritoneal Adhesiolysis with MCC: Inpatient Reimbursement Overview

    Showing 1–10 of 57

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.